Company: HCWB
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0000950170-25-046724
Chunk: 337

Company: HCW Biologics Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1B
Chunk 337
---
2024, by and among the Company, Escrow Agent and Noteholder parties thereto
     
    10-Q
     
    011-40591
     
    10.4
     
    8/14/2024

    10.25
     
    Form of First Amendment to the Amended and Restated Senior Secured Note Purchase Agreement, dated September 30, 2024, by and between the Company and Purchaser parties thereto
     
    10-Q
     
    011-40591
     
    10.5
     
    11/14/2024

    10.26
     
    Settlement Agreement and Release, dated July 13, 2024, by and between the Company and Altor BioScience, LLC, NantCell, Inc., and ImmunityBio, Inc.
     
    10-Q
     
    011-40591
     
    10.6
     
    11/14/2024

    10.27
     
    License, Research and Co-Development Agreement with WY Biotech dated November 17, 2024

    X

    10.28
     
    Letter Agreement for Principal Terms for the Amendment of the License, Research and Co-Development Agreement with WY Biotech dated March 17, 2025 and Company’s Letter to Agree and Accept dated March 19, 2025

    X

    10.29
     
    Placement Agency Agreement, dated November 18, 2024, between Company and Maxim Group LLC
     
    8-K
     
    011-40591
     
    10.1
     
    11/20/2024

    10.30
     
    Securities Purchase Agreement, dated November 18, 2024, between the Company and Purchaser
     
    8-K
     
    011-40591
     
    10.2
     
    11/20/2024

    10.31
     
    Form of Common Stock Warrant Purchase Agreement, dated November 18, 2024, between Company and Holder
     
    8-K
     
    011-40591
     
    4.1
     
    11/20/2024